Green tea catechins: a fresh flavor to anticancer therapy (Q38147993)

29 August 2017

Green tea catechins: a fresh flavor to anticancer therapy (English)

1 reference

29 August 2017

0 references

Yang Yu

1

1 reference

29 August 2017

Yuan Deng

2

1 reference

29 August 2017

Bang-Min Lu

3

1 reference

29 August 2017

Yong-Xi Liu

4

1 reference

29 August 2017

Jian Li

5

1 reference

29 August 2017

Jin-Ku Bao

6

1 reference

29 August 2017

1 January 2014

1 reference

29 August 2017

1 reference

29 August 2017

19

1 reference

29 August 2017

1

1 reference

29 August 2017

1-18

1 reference

https://scigraph.springernature.com/pub.10.1007/s10495-013-0908-5

29 August 2017

0 references

cites work

The chemistry and biotransformation of tea constituents

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Cancer prevention by tea: animal studies, molecular mechanisms and human relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Metabolism of green tea catechins: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Angiogenesis inhibited by drinking tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Tea and cancer prevention: molecular mechanisms and human relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Efficient procedure for isolating methylated catechins from green tea and effective simultaneous analysis of ten catechins, three purine alkaloids, and gallic acid in tea by high-performance liquid chromatography with diode array detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz(a)anthracene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Chemopreventive effect of aerosolized polyphenon E on lung tumorigenesis in A/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea polyphenols for prostate cancer chemoprevention: a translational perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea consumption and risk of stomach cancer: a meta-analysis of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea consumption and risk of esophageal cancer: a meta-analysis of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Smoking, green tea consumption, genetic polymorphisms in the insulin-like growth factors and lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Molecular mechanism of the inhibition of EGCG on the Alzheimer Aβ(1-42) dimer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Dietary polyphenolic phytochemicals--promising cancer chemopreventive agents in humans? A review of their clinical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea and cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Cancer chemoprevention with dietary phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Tea catechin consumption reduces circulating oxidized low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Carcinogenesis, cancer therapy and chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Cell cycle control of DNA replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

G1 cell-cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Anti-proliferative effects of green tea polyphenol EGCG on Ha-Ras-induced transformation of intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-κB in human dermal fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Targeting RAS signalling pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

The tea polyphenols EGCG and EGC repress mRNA expression of human telomerase reverse transcriptase (hTERT) in carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Molecular targets of dietary agents for prevention and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Multitargeted therapy of cancer by green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Cellular signaling perturbation by natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Molecular targets for the cancer preventive activity of tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

A receptor for green tea polyphenol EGCG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

The role of the IGF system in cancer growth and metastasis: overview and recent insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Possible mechanisms of the cancer-preventive activities of green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Nutraceuticals, apoptosis, and disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Biochemical pathways of caspase activation during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Caspase activation: the induced-proximity model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

G-protein-coupled receptors and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

(-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Cancer and metastasis: prevention and treatment by green tea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Inhibitory effect of epigallocatechin gallate on adhesion of murine melanoma cells to laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

The modulation of endothelial cell gene expression by green tea polyphenol-EGCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Cancer stem cells: potential target for bioactive food components

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

New cancer treatment strategy using combination of green tea catechins and anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

The combination of green tea and tamoxifen is effective against breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Keratinocyte proliferation, differentiation, and apoptosis--differential mechanisms of regulation by curcumin, EGCG and apigenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Pancreatic cancer chemoprevention by phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Cancer-preventive effects of drinking green tea among a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Tumor invasion: molecular shears blunted by green tea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

Why drinking green tea could prevent cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0908-5

10.1007/S10495-013-0908-5

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference